Is remdesivir effective in coronavirus treatment? China study says No, US says Yes
The efficacy of antiviral drug remdesivir in treatment of coronavirus has become a bone of contention with contrary claims coming from the US and China. US government official Anthony Fauci has vouched for remdesivir after a clinical trial in the US found that patients who were given remdesivir recovered 31 per cent faster than those given a placebo. Fauci, while speaking at the White House, said data from one clinical trial shows that remdesivir has a clear-cut, significant, positive effect in diminishing the time to recovery. Drugmaker Gilead too claimed there were signs that remdesivir could be useful, possibly in patients with milder versions of the disease. However, a study in China seems to suggest otherwise. The study carried out by China-Japan Friendship Hospital and Capital Medical University found remdesivir did not significantly speed up recovery in COVID-19 patients, medical journal Lancet reported. The study was conducted on 237 adult patients - aged 18 ...